CNGB1-related rod-cone dystrophy: A mutation review and update.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nassisi Marco, Smirnov Vasily M, Solis Hernandez Cyntia, Mohand-Saïd Saddek, Condroyer Christel, Antonio Aline, Kühlewein Laura, Kempf Melanie, Kohl Susanne, Wissinger Bernd, Nasser Fadi, Ragi Sara D, Wang Nan-Kai, Sparrow Janet R, Greenstein Vivienne C, Michalakis Stylianos, Mahroo Omar A, Ba-Abbad Rola, Michaelides Michel, Webster Andrew R, Degli Esposti Simona, Saffren Brooke, Capasso Jenina, Levin Alex, Hauswirth William W, Dhaenens Claire-Marie, Defoort-Dhellemmes Sabine, Tsang Stephen H, Zrenner Eberhart, Sahel Jose-Alain, Petersen-Jones Simon M, Zeitz Christina, Audo Isabelle
Аннотация
Cyclic nucleotide-gated channel β1 (CNGB1) encodes the 240-kDa β subunit of the rod photoreceptor cyclic nucleotide-gated ion channel. Disease-causing sequence variants in CNGB1 lead to autosomal recessive rod-cone dystrophy/retinitis pigmentosa (RP). We herein present a comprehensive review and analysis of all previously reported CNGB1 sequence variants, and add 22 novel variants, thereby enlarging the spectrum to 84 variants in total, including 24 missense variants (two of which may also affect splicing), 21 nonsense, 19 splicing defects (7 at noncanonical positions), 10 small deletions, 1 small insertion, 1 small insertion-deletion, 7 small duplications, and 1 gross deletion. According to the American College of Medical Genetics and Genomics classification criteria, 59 variants were considered pathogenic or likely pathogenic and 25 were variants of uncertain significance. In addition, we provide further phenotypic data from 34 CNGB1-related RP cases, which, overall, are in line with previous findings suggesting that this form of RP has long-term retention of useful central vision despite the early onset of night blindness, which is valuable for patient counseling, but also has implications for it being considered a priority target for gene therapy trials.